Skip to main content
. 2022 Apr 28:e220615. Online ahead of print. doi: 10.1001/jamaoncol.2022.0615

Table 2. Summary of Adverse Events.

Adverse event RT arm (n = 30) TOS and ND arm (n = 31) P valuea
G1 G2 G3 G4 G5 G1 G2 G3 G4 G5
Anemia 0 0 1 0 0 0 0 0 0 0 .49
Anorexia 2 6 2 0 0 5 1 0 0 0 .01
Bone infection 0 0 0 0 0 0 0 0 0 1 >.99
Constipation 6 1 0 0 0 0 1 0 0 0 >.99
Dehydration 0 1 0 0 0 0 0 0 0 0 .49
Dermatitis (radiation) 12 5 1 0 0 11 5 0 0 0 .69
Dry mouth 19 5 0 0 0 15 4 0 0 0 .73
Dysarthria 0 0 0 0 0 0 1 0 0 0 >.99
Dysgeusia 14 11 0 0 0 10 4 0 0 0 .03
Dyspepsia 0 1 0 0 0 0 0 0 0 0 .49
Dysphagia 7 7 0 0 0 9 5 2 0 0 .94
Fatigue 9 7 0 0 0 9 3 1 0 0 .29
Febrile neutropenia 0 0 1 0 0 0 0 0 0 0 .49
Fever 2 2 0 0 0 0 0 0 0 0 .24
Gastrointestinal disorder 2 0 0 0 0 5 1 0 0 0 >.99
Hearing loss (based on audiogram) 1 1 0 0 0 0 0 0 0 0 .49
Hearing impairment (patient reported) 4 2 0 0 0 0 0 0 0 0 .24
Hypokalemia 0 1 0 0 0 0 0 0 0 0 .49
Hypomagnesemia 0 1 0 0 0 0 0 0 0 0 .49
Infection (other) 0 1 0 0 0 0 0 0 0 0 .49
Joint range of motion decreased 0 0 0 0 0 2 0 1 0 0 >.99
Lung infection 0 0 0 0 0 0 0 3 0 0 .24
Lymph leakage 0 0 0 0 0 0 1 0 0 0 >.99
Mucositis (oral) 9 5 1 0 0 3 3 1 0 0 .51
Musculoskeletal and connective tissue disorder 0 1 0 0 0 1 0 0 0 0 .49
Nausea 11 1 0 0 0 4 1 0 0 0 >.99
Neck pain 1 1 0 0 0 3 1 0 0 0 >.99
Neutrophil count decreased 0 1 1 1 0 0 0 0 0 0 .11
Oral hemorrhage 0 0 0 0 0 0 3 1 0 1 .05
Oral/oropharyngeal pain 9 2 0 0 0 5 4 0 0 0 .67
Osteonecrosis of jaw 0 0 0 0 0 0 1 0 0 0 >.99
Pain (not otherwise specified) 5 5 1 0 0 5 7 0 0 0 .81
Peripheral sensory neuropathy 1 0 1 0 0 2 0 0 0 0 .49
Rash (maculopapular) 0 0 0 0 0 0 1 0 0 0 >.99
Skin ulceration 0 1 0 0 0 0 1 0 0 0 >.99
Thromboembolic event 0 0 1 0 0 0 0 0 0 0 .49
Thrush 2 0 0 0 0 1 2 0 0 0 .49
Tinnitus 5 1 0 0 0 0 0 0 0 0 .49
Trismus 0 1 0 0 0 5 3 2 0 0 .20
Vomiting 4 0 0 0 0 0 1 0 0 0 >.99
Weight loss 8 2 0 0 0 11 3 0 0 0 >.99
White blood cell count decreased 0 1 0 0 0 0 0 0 0 0 .49

Abbreviations: G, grade; RT, radiotherapy; TOS and ND, transoral surgery and neck dissection.

a

P values calculated based on rates of grade 2 or greater adverse events using the χ2 or Fisher exact test as appropriate.